Blue Ocean Medicines

Partnering — Seeking Innovative Therapeutic Assets

Blue Ocean Medicines. Partnering. Seeking Innovative Therapeutic Assets. Licensing, Co-Development, Strategic Partnerships. Transforming bold science into shareholder value. Areas of Interest: Oncology, Immunology, Metabolic Disease. Preferred Development Stage: IND-Enabling, IND Ready, Phase 1, Early Phase 2. How We Partner: Licensing, Co-Development, Strategic Partnerships, Asset Acquisition. Blue Ocean Medicines. Accelerating clinical proof-of-concept.
Blue Ocean Medicines. Partnering. Seeking Innovative Therapeutic Assets. Licensing, Co-Development, Strategic Partnerships. Transforming bold science into shareholder value. Areas of Interest: Oncology, Immunology, Metabolic Disease. Preferred Development Stage: IND-Enabling, IND Ready, Phase 1, Early Phase 2. How We Partner: Licensing, Co-Development, Strategic Partnerships, Asset Acquisition. Blue Ocean Medicines. Accelerating clinical proof-of-concept.